NCT04542837 The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT04530240 Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy Status COMPLETED Phase N/A
NCT04522544 Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC Status RECRUITING Phase PHASE2
NCT04472767 Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT04455932 HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation Status RECRUITING Phase NA
NCT04251117 GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04232722 Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation Status UNKNOWN Phase PHASE2
NCT04195971 Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension Status UNKNOWN Phase NA
NCT04173520 ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy Status COMPLETED Phase N/A
NCT04172506 A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04165174 PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT Status UNKNOWN Phase PHASE2
NCT04123340 Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation Status COMPLETED Phase PHASE2
NCT04069416 Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria Status COMPLETED Phase N/A
NCT04032860 RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03985644 Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma Status UNKNOWN Phase N/A